Adjuvant therapy of Nivolumab combined with Ipilimumab versus Nivolumab alone in patients with resected stage IIIB-D or stage IV melanoma (CheckMate 915)

DSpace Repository

Adjuvant therapy of Nivolumab combined with Ipilimumab versus Nivolumab alone in patients with resected stage IIIB-D or stage IV melanoma (CheckMate 915)

Author: Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Pigozzo, Jacopo; Gogas, Helen; Dalle, Stephane; Meyer, Nicolas; Ascierto, Paolo A.; Sandhu, Shahneen; Eigentler, Thomas; Gutzmer, Ralf; Hassel, Jessica C.; Robert, Caroline; Carlino, Matteo S.; Di Giacomo, Anna Maria; Butler, Marcus O.; Munoz-Couselo, Eva; Brown, Michael P.; Rutkowski, Piotr; Haydon, Andrew; Grob, Jean-Jacques; Schachter, Jacob; Queirolo, Paola; de la Cruz-Merino, Luis; Haydon, Andrew; Grob, Jean-Jacques; Schachter, Jacob; Queirolo, Paola; De La Cruz-Merino, Luis; van der Westhuizen, Andre; Menzies, Alexander M.; Re, Sandra; Bas, Tuba; de Pril, Veerle; Braverman, Julia; Tenney, Daniel J.; Tang, Hao; Long, Georgina, V
Tübinger Autor(en):
Eigentler, Thomas
Published in: Journal of Clinical Oncology (2023), Bd. 41, H. 3, S. 517-527
Verlagsangabe: Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1200/JCO.22.00533
ISSN: 0732-183X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)